FREELAND: CANADA WON'T ESCALATE OR BACK DOWN ON US TRADE FIGHT

MNI: PBOC To Aim To Drive Inflation Higher- Advisors

MNI: China To Issue More Bonds As Stimulus Targets Consumption

MNI: PBOC To Aim To Drive Inflation Higher- Advisors

MNI: China To Issue More Bonds As Stimulus Targets Consumption

MNI BRIEF: China Nov M1 Decline Narrows, M2 Slows

EZ/UK T-Bill Calendar: 8/13/28/50-Week BTF Auction on Monday

EZ/UK Bond Supply Calendar: 4.125% Jul-29 Gilt Due on Tuesday

MNI: CANADA OCT WHOLESALE SALES +3.3%; EX-AUTOS +0.5%

MNI EXCLUSIVE: EU-Mercosur Deal Close, But Likely Short-Lived - Officials

AUSTRALIA: 2025 Election Outcome Looking More Uncertain According To Newspoll

© 1982-2024 MNI. All rights reserved.
Terms | Privacy
Log Out
Free Trial

Equities surge on drug news, but FX less......>

FOREX
FOREX: Equities surge on drug news, but FX less forthcoming
- European equities trade very healthily early Friday, with US futures following
suit, after an optimistic report on Gilead's Remdesivir drug for treatment of
those with COVID-19. The Stat report stated those receiving the treatment were
"seeing rapid recoveries in fever and respiratory symptoms". Following the surge
in US futures, mainland European indices are higher by 2-3% ahead of the NY
crossover.
- The greenback is mixed, with GBP and NOK among the poorer performers.
Newsflows and data has been light so far, keeping most major pairs well within
recent ranges. Chinese GDP data overnight was poor, but no surprise, with the
economy shrinking near 10% in Q1. EMFX is more mixed, with ZAR on the front foot
while TRY trails slightly. 
- There are no data releases of note Friday, leaving focus on speeches scheduled
from Fed's Bullard and ECB's Rehn. This will likely keep attention on any
further evidence into the weekend on the global COVID-19 curve as further plans
are published on emerging from lockdown.
Energy BulletsCommodities
Energy BulletsCommodities

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.